Weight loss has long been a challenging topic for both patients and physicians, often preventing those living with obesity and overweight from seeking medical treatment altogether. Weight stigma and bias have no place in healthcare. At Form Health, we recognize obesity as a complex, chronic medical condition. Our team of expert doctors, Advanced Practice Providers (APPs), and Registered Dietitians work together to provide nonjudgmental, empathetic, and evidence-based obesity care for all. Want to learn more? Email us at employers@formhealth.co.
Form Health
Hospitals and Health Care
Boston, Massachusetts 3,493 followers
Form Health is the national leader in science-based obesity care.
About us
Form Health is the national leader in science-based obesity care. Our clinical care model consists of one-on-one, personalized care from a dedicated ABOM-certified physician and a CSOWM-certified Registered Dietitian, who develop individualized treatment plans that address nutrition, physical activity, mindset shifts, and include a prescription for FDA-approved medication, if appropriate. Form Health keeps safety, efficacy, and outcomes at the forefront as we incorporate the latest research and science into our approach. This means we’re always innovating, constantly getting smarter about the science of obesity care, relentlessly focusing on exceptional results, and calling out harmful practices that hold back progress. The result is life-changing outcomes for our patients and meaningful ROI for our enterprise partners. Form Health is in-network with national health plans. Learn more at formhealth.co.
- Website
-
http://formhealth.co
External link for Form Health
- Industry
- Hospitals and Health Care
- Company size
- 51-200 employees
- Headquarters
- Boston, Massachusetts
- Type
- Privately Held
- Founded
- 2019
Locations
-
Primary
Get directions
109 State St
5th Floore
Boston, Massachusetts 02109, US
Employees at Form Health
Updates
-
Form Health physician Nat Pedley shares what it's like to be part of the Form team and how practicing telemedicine provides an opportunity to build meaningful relationships with his patients. Excited about making a difference in healthcare and helping patients reach their weight loss and health goals? Join our team of obesity medicine specialists! Explore our job opportunities: https://lnkd.in/dZUp2V6p
-
Check out more about Form Health’s Series B in the The Wall Street Journal today.
Obesity Telehealth Startup Form Health Raises $38 Million
wsj.com
-
Form Health is thrilled to announce our Series B funding. Form was founded to fundamentally change the way obesity care is delivered to Americans. We keep safety, efficacy, and outcomes at the forefront as we incorporate the latest research and science into our approach. This means we’re always innovating, constantly getting smarter about the science of obesity care, relentlessly focusing on exceptional results, and calling out harmful practices that hold back progress. The result is life-changing outcomes for our patients and meaningful ROI for our partners. With the new funding, we’ll be expanding our work with our enterprise partners, including employers, consultants and health plans, deeply investing in product and accelerating the hiring of ABOM-certified physicians to keep up with extraordinary patient demand. Thank you to the team at Sound Ventures for partnering with us during this exciting period of our growth, and the folks at M13, SignalFire, and NextView Ventures for continuing to believe in our mission to greatly expand access to science-based obesity care.
-
FORM CMO Florencia Halperin reinforces the importance of nutritional support for patients taking GLP-1 and GIP receptor agonists. Registered Dietitians can play a critical role in helping patients manage any risk of malnutrition and set sustainable dietary goals during AOM therapy. At FORM patients receive comprehensive obesity care by working 1:1 with both an ABOM doctor and a CSOWM Registered Dietitian. Want to learn more about our science-based approach? Reach out to employers@formhealth.co.
All of us who are actively treating patients with obesity using the newest, highly effective medications (GLP-1 +/- GIP receptor agonists) are seeing how important it is to give our patients nutrition support and education as their appetites become suppressed and their cravings subside. But we don't have a ton of current data to guide nutritional recommendations during AOM therapy specifically. This recent review highlights that nutritional assessment and counseling of patients on AOMs can help us identify and manage risk factors for malnutrition, develop goals for intake of key nutrients like protein, fiber, vitamins, and fluids. Not that we were looking for any additional reason to love working with our registered dietitian colleagues, but it is great to read an evidence-based review that highlights their crucial role in obesity care even when people use highly effective AOMs. My patients and I are so lucky to have the incredible RDs on our team at FORM │ Virtual obesity medicine clinic.
onlinelibrary.wiley.com
-
We are excited for today's Northeast Business Group on Health Annual Health and Wellness Benefits Conference! Don't miss our CMO, Florencia Halperin, who will be speaking on the "GLP-1s: It's Complicated" panel this afternoon. Interested to learn how FORM can support your organization provide access to clinical obesity care that delivers real results and ROI? Stop by table #4 and connect with Brian Walker at the event or email employers@formhealth.co
-
-
It is great to see studies conducted to help us establish that while obesity treatments lead to weight loss - perhaps even more importantly - they help prevent progression of metabolic disease," says FORM CMO Florencia Halperin. At Form Health, we treat obesity as a chronic disease with science-based, comprehensive care. Is your organization seeking an impactful and cost-effective solution to address the high cost of obesity and metabolic disease? Contact employers@formhealth.co to learn how we can help.
We are fortunately moving towards greater recognition that treating obesity is an important way to prevent and treat cardiometabolic co-morbidities. New studies are looking at how anti-obesity medications affect biopsy-proven Metabolic dysfunction–Associated SteatoHepatitis, or MASH. Tirzepatide (a dual agonist of GIP and GLP-1 receptors) treatment in MASH with moderate to severe fibrosis significantly increased resolution of MASH, without worsening fibrosis (by 62% at the highest dose). Survodutide (a novel dual agonist of glucagon and GLP-1 receptors) treatment in MASH and fibrosis (https://lnkd.in/ee6MQdDJ) in a phase 2 trial showed a reduction in MASH with no worsening of fibrosis, a decrease in liver fat by 30% and in fibrosis by at least one stage. MASH is part of the many cardiometabolic complications of obesity that reduce life expectancy. Losing weight is a key intervention. It is great to see studies conducted to help us establish that while obesity treatments lead to weight loss - perhaps even more importantly - they help prevent progression of metabolic disease.
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis | NEJM
nejm.org
-
The AP Stylebook, a writing and editing reference for newsrooms, classrooms, and corporate offices, recently adopted a people-first language approach to obesity. What does that mean? They recommend using the phrase "person with obesity" instead of using the term "obese" as an adjective to describe a person. This may seem like a small change, but it's a huge step forward in reducing bias and stigma by framing obesity as a disease. Form Health is committed to using people-first language and providing nonjudgmental treatment for all patients with obesity. Is your organization looking for a partner to deliver impactful and cost-effective obesity treatment? Form Health can help. Get in touch at employers@formhealth.co.
AP Stylebook Announces Historic Merriam-Webster Collaboration at ACES 2024 San Diego
aceseditors.org
-
Get to know Form Health Director of Nutrition, Registered Dietitian Julia Axelbaum, RD, CSOWM, and what she enjoys about providing patient care via Telehealth. If you're driven to transform healthcare and assist patients in reaching their weight loss and health goals, we'd love to have you on our team of obesity medicine specialists! Check out our career opportunities: https://lnkd.in/dZUp2V6p
-
In NYC next week for the Northeast Business Group on Health Annual Health and Wellness Benefits Conference? Don't miss our Form Health Chief Medical Officer, Florencia Halperin, who will be on the panel "GLP-1s: It's Complicated" to share her insights about how employers can provide access to clinical obesity care that delivers results and ROI. Be sure to connect with Jen Cressman and Brian Walker during the event or stop by table 4 to discover how Form Health can help your organization. Not attending but want to learn more? Email us at employers@formhealth.co.
-